DrugPatentWatch Database Preview

Par Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for PAR PHARM, and what generic alternatives to PAR PHARM drugs are available?

PAR PHARM has two hundred and fourteen approved drugs.

There is one US patent protecting PAR PHARM drugs. There are fourteen tentative approvals on PAR PHARM drugs.

Summary for Par Pharm

US Patents:	1
Tradenames:	128
Ingredients:	125
NDAs:	214
Patent Litigation for Par Pharm:	See patent lawsuits for Par Pharm
PTAB Cases with Par Pharm as petitioner:	See PTAB cases with Par Pharm as petitioner

Drugs and US Patents for Par Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Pharm	FLURAZEPAM HYDROCHLORIDE	flurazepam hydrochloride	CAPSULE;ORAL	070444-001	Mar 20, 1986		DISCN	No	No
Par Pharm	RISPERIDONE	risperidone	TABLET, ORALLY DISINTEGRATING;ORAL	077494-003	Oct 26, 2009	AB	RX	No	No
Par Pharm	SULFINPYRAZONE	sulfinpyrazone	TABLET;ORAL	088933-001	Sep 6, 1985		DISCN	No	No
Par Pharm	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	070595-001	Sep 11, 1986		DISCN	No	No
Par Pharm	SUMYCIN	tetracycline hydrochloride	TABLET;ORAL	061147-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Par Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Par Pharm Inc	ACCOLATE	zafirlukast	TABLET;ORAL	020547-003	Sep 17, 1999	5,294,636
Par Pharm Inc	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	5,583,152
Par Pharm	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995	4,258,027
Par Pharm Inc	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	4,859,692
Par Pharm	NASCOBAL	cyanocobalamin	GEL, METERED;NASAL	019722-001	Nov 5, 1996	4,724,231

Paragraph IV (Patent) Challenges for PAR PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Nasal Spray	500 mcg/spray		2017-04-28
	Tablets	10 mg and 20 mg		2008-02-29

International Patents for Par Pharm Drugs

Country	Document Number	Estimated Expiration
European Patent Office	1948613
World Intellectual Property Organization (WIPO)	2006115626
Canada	2605413
South Korea	20080000660
Japan	2008538560

Supplementary Protection Certificates for Par Pharm Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
99C0030	Belgium		PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
00C/005	Belgium		PRODUCT NAME: DOFETILIDE; REGISTRATION NO/DATE: EU/1/99/121/001 19991129
C0022	France		PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
14/058	Ireland		PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
2012017,C1920764	Lithuania		PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Par Form
• Par Pharm
• Par Pharm Inc
• Par Sterile Products